Skip to main content
Skip to footer

TCS ADD™ hosted a Virtual Event to provide insights into the next generation of product labeling. Thought leaders from AbbVie, Merck and TCS presented their views on pharma labeling, analyzed the role of modern technologies to support labeling and shared real-life examples of successful industry implementations.


  • Khyati Roberts - Head, US/Canada Regulatory Policy and Intelligence, AbbVie
  • Laura Robinson Campbell - AVP, Regulatory Affairs, Merck, Sharp & Dohme Corp, Kenilworth, NJ
  • Mohit Gupta – Former Head, TCS ADD™ Regulatory, TCS


  • Dr. Hilde Vanaken - Head of Industry Leaders, TCS Life Sciences & Healthcare


Key Focus Areas

  • Identifying the next generation product labeling approaches
  • Challenges and roadblocks encountered
  • Role played by technology to accelerate adoption
  • Real-life pharma experiences and use cases
  • Key takeaways from the session

Product labeling is a highly regulated and complex process in pharma and is a critical component of product approvals. Healthcare providers and patients need to have access to the most up-to-date information about a product in an easy-to-understand and accessible manner, to facilitate fully informed and safe decision-making. Thus, it becomes imperative to drive innovation and modernization into the management of product information and transform the labeling process by leveraging technology to achieve reduced cycle time and costs while ensuring consistency, accuracy, and quality in labeling.

  1. For more info on TCS ADD™ Platform Click here 
  2. For more info on TCS ADD™ Regulatory  Click here
Contact Contact